End-of-day quote
Other stock markets
|
||
- USD | - |
05-14 | Transcript : GeoVax Labs, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
03-28 | GeoVax Labs, Inc. to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress | CI |
Chart calendar Geovax Labs Inc
Upcoming events on Geovax Labs Inc
Past events on Geovax Labs Inc
01/05/2024 | Q1 2024 Earnings Release (Projected) |
04/04/2024 17:00 | World Vaccine Congress |
18/03/2024 21:30 | Roth Conference |
29/02/2024 21:30 | Q4 2023 Earnings Call |
29/02/2024 21:00 | Q4 2023 Earnings Release |
26/02/2024 21:15 | BIO CEO & Investor Conference |
30/01/2024 | Reverse Split: 1 of 15 |
08/01/2024 22:30 | Biotech Showcase |
06/12/2023 20:25 | Emerging Growth Conference |
04/12/2023 15:00 | Noble Capital Markets Emerging Growth Equity Conference |
30/11/2023 21:40 | West Coast World Vaccine Congress |
29/11/2023 00:20 | West Coast World Vaccine Congress |
14/11/2023 13:00 | Vaccines Summit |
08/11/2023 21:30 | Q3 2023 Earnings Call |
08/11/2023 21:00 | Q3 2023 Earnings Release |
05/11/2023 | Bio-Europe Conference |
02/11/2023 19:55 | Emerging Growth Virtual Conference |
12/10/2023 18:30 | Dawson James Small Cap Growth Conference |
05/10/2023 20:30 | BioFuture |
04/10/2023 20:25 | Emerging Growth Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 1,82 0,00 - | 0,39 0,22 75.23% | 0,08 0,06 34.38% | 0,00 0,00 - | 0,00 |
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | -13,1 -9,30 -40.46% | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -2,82 -2,08 -35.49% | -18,7 -7,48 -150.55% | -14,0 -13,8 -1.58% | -26,7 -24,1 -11.15% | -32,4 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -2,96 -2,22 -33.19% | -18,6 -7,14 -160.23% | -14,0 -13,8 -1.54% | -26,0 -23,2 -11.71% | -31,7 |
Net income Million USD | Released Forecast Spread | -2,37 | -2,96 -2,22 -33.19% | -18,6 -7,14 -160.23% | -14,0 -13,8 -1.54% | -26,0 -23,2 -11.71% | -31,7 |
EPS USD | Released Forecast Spread | -11 775 | -32,1 -4,05 -692.59% | -45,6 -17,7 -157.63% | -12,4 -12,0 -3.75% | -14,3 -14,5 1.79% | -10,0 |
Announcement Date | 24/03/20 | 23/03/21 | 09/03/22 | 23/03/23 | 29/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,16 0,00 - | 0,08 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -13,7 -2,48 -454.18% | -2,43 -2,84 14.51% | -2,24 -2,84 20.92% | -3,97 -2,50 -58.82% | -5,39 -5,12 -5.16% | -4,27 -5,93 27.92% | -6,18 -4,55 -35.8% | -8,60 -6,00 -43.33% | -7,69 -7,43 -3.62% | ||||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,7 -2,48 -454.15% | -2,43 -2,84 14.52% | -2,24 -2,84 20.92% | -3,97 -2,50 -58.72% | -5,38 -5,12 -5.1% | -4,04 -5,92 31.84% | -5,93 -4,46 -32.97% | -8,41 -5,83 -44.15% | -7,59 -7,34 -3.48% | ||||
Net income Million USD | Released Forecast Spread | -13,7 -2,48 -454.15% | -2,43 -2,84 14.52% | -2,24 -2,84 20.92% | -3,97 -2,50 -58.72% | -5,38 -5,12 -5.1% | -4,04 -5,92 31.84% | -5,93 -4,46 -32.97% | -8,41 -5,83 -44.15% | -7,59 -7,34 -3.48% | ||||
EPS USD | Released Forecast Spread | -33,6 -6,00 -460% | -5,10 -4,65 -9.68% | -2,70 -4,50 40% | -2,55 -1,80 -41.67% | -3,00 -3,00 0% | -2,25 -3,38 33.33% | -3,30 -2,55 -29.41% | -4,80 -3,60 -33.33% | -3,94 -4,20 6.19% | -2,47 -5,56 55.58% | -5,82 | -1,61 | -1,74 |
Announcement Date | 09/03/22 | 27/04/22 | 03/08/22 | 09/11/22 | 23/03/23 | 04/05/23 | 09/08/23 | 08/11/23 | 29/02/24 | 14/05/24 | - | - | - |
15/05/2024 | REPLIMUNE GROUP, INC.: Q4 2024 Earnings Release (Projected) |
17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
20/05/2024 | ALVOTECH: Q1 2024 Earnings Release |
21/05/2024 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
21/05/2024 | EXSCIENTIA PLC: Q1 2024 Earnings Release (Projected) |
21/05/2024 | EVOTEC SE: Q1 2024 Earnings Release |
30/06/2024 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
Past sector events for Geovax Labs Inc
Today | GNI GROUP LTD.: Q1 2024 Earnings Release |
14/05/2024 12:30 | ABSCI CORPORATION: Q1 2024 Earnings Release |
13/05/2024 | BELITE BIO, INC: Q1 2024 Earnings Release |
13/05/2024 | POLARIS GROUP: Q1 2024 Earnings Release |
13/05/2024 21:30 | AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
13/05/2024 12:00 | APOGEE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
13/05/2024 00:00 | PRAXIS PRECISION MEDICINES, INC.: Q1 2024 Earnings Release |
13/05/2024 11:30 | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
13/05/2024 21:10 | CENTESSA PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
12/05/2024 | BIOMEA FUSION, INC.: Q1 2024 Earnings Release (Projected) |
- Stock Market
- Equities
- GOVX Stock
- Stock
- Calendar Geovax Labs Inc